Mainstream

Arcturus Up 9% As Phase 2 Dosing Begins For Mrna Asset For Cystic Fibrosis

Arcturus up 9% as phase 2 dosing begins for mRNA asset for cystic fibrosis

Arcturus up 9% as phase 2 dosing begins for mRNA asset for cystic fibrosis

Post ContentarctRead More

You might also be interested in reading Plaid suspends FTX.US access to user data after ‘concerning’ reports.

January 7, 2025
In Mainstream